MFAIX
Morgan Stanley Institutional Fund, Inc. International Advantage Portfolio Class I
Expense Ratio Rating
7 /10
Expense Rating
0 /10
Market Score
7 /10
Category Score
8 /10
Market Size
7 /10
$MFAIX Alternatives
Different Funds
We found 9,394 International Stocks Large Growth funds. Here they are ordered by FI Score.
- vfpax
- Mutual Fund
- US Stocks
- Small Blend
Private Capital Management Value Fund Class A
Expenses: 1.35% (Better than 0% of similar funds)
This is a bad choice for a Small Blend US Stocks fund. See why »
- pufbx
- Mutual Fund
- Sector Equity
- Financial Services
PGIM Jennison Financial Services Fund- Class B
Expenses: 2.31% (Better than 0% of similar funds)
This is a bad choice for a Financial Services Sector Equity fund. See why »
- ryvnx
- Mutual Fund
- Alternative
- Inverse
Rydex Inverse NASDAQ-100® 2x Strategy Fund Class H
Expenses: 1.88% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternative fund. See why »
- spdcx
- Mutual Fund
- Allocation
- All-In-One
DWS Multi-Asset Conservative Allocation Fund - Class C
Expenses: 1.41% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- rgscx
- Mutual Fund
- Allocation
- Total World
AllianzGI Global Small-Cap Fund Class C
Expenses: 2.37% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- rmicx
- Mutual Fund
- Allocation
- All-In-One
RiverFront Asset Allocation Moderate Class C
Expenses: 1.25% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- rsgfx
- Mutual Fund
- US Stocks
- Mid-Cap Growth
Victory RS Select Growth Fund Class C
Expenses: 2.18% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »
- ryahx
- Mutual Fund
- Alternative
- Leveraged Equities
Rydex Mid-Cap 1.5x Strategy Fund Class A
Expenses: 1.75% (Better than 0% of similar funds)
This is a bad choice for a Leveraged Equities Alternative fund. See why »
- rybox
- Mutual Fund
- Sector Equity
- Healthcare
Rydex Biotechnology Fund Class A
Expenses: 1.71% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »